𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant therapy of breast cancer: The Southwest Oncology Group experience

✍ Scribed by William A. Knight; Saul E. Rivkin; Harold Glucksberg; Mary A. Foulkes; John J. Costanzi; Ronald L. Stephens; John W. Athens; Robert M. O'Bryan

Publisher
Springer US
Year
1983
Tongue
English
Weight
598 KB
Volume
3
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant therapy of osteosarcomaβ€”A Phase
Adjuvant therapy of osteosarcomaβ€”A Phase II trial : Southwest Oncology Group study 9139
✍ Mark M. Zalupski; Cathryn Rankin; James R. Ryan; David R. Lucas; Jeffrey Muler; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 101 KB

## Abstract ## BACKGROUND The objective of this study was to estimate the time to treatment failure and survival rate of the three‐drug combination of doxorubicin, cisplatin, and ifosfamide as primary and postoperative, adjunctive treatment for teenagers and adults with osteosarcoma (OS). ## METH

Adriamycin in combination for the treatm
Adriamycin in combination for the treatment of breast cancer. A southwest oncology group study
✍ Dr. B. Tranum; B. Hoogstraten; A. Kennedy; C. B. Vaughn; B. Samal; T. Thigpen; S πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 431 KB πŸ‘ 2 views

Patients with advanced breast cancer who had not previously received chemotherapy were treated on a three-arm prospective study: adriamycin day 1 plus 5-FU on day 1 and 8 (AF), adriamycin day 1 , plus 5-FU day 1 and 8 , and cyclophosphamide day 1 (AFC), and adriamycin day 1 plus 5-FU day 1 and 8 , c